England ’s Health Service Enters Biggest-Ever Week Of Strikes
Nurses, ambulance staff and physiotherapists at public hospitals in England are set to walk out this week over long-standing pay disputes. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 7, 2023 Category: Pharmaceuticals Authors: Katherine Hignett, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Women Who Live Healthy Lifestyles May Reduce Their Risk Of Long Covid By Half, Study Suggests
Between eight and 23 million Americans suffer from long Covid. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 6, 2023 Category: Pharmaceuticals Authors: Ana Faguy, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news

How We Can Make Progress Fixing Some Of The World ’s Biggest Challenges
To move the ball forward and truly make our world a better place to call home in 2023 and beyond, we must put our minds, power and money toward solving longstanding global problems and challenges left unresolved last year. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 6, 2023 Category: Pharmaceuticals Authors: Gayle E. Smith, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Australia The First Nation To Approve The Legal Use Of MDMA And Psilocybin
Psychedelic drugs are at last being recognized by governments around the world as potentially life-saving medicines. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 6, 2023 Category: Pharmaceuticals Authors: David E. Carpenter, Contributor Tags: Vices /vices Lifestyle /lifestyle Innovation /innovation Healthcare /healthcare davidcarpenterblog Source Type: news

Expert Panel Recommends Restrictions On Dangerous Gain-Of-Function Research. Virologists Are Already Pushing Back
This past week, a government-appointed panel of scientists released a new report recommending 13 things the government should do to control “gain-of-function” research that has the potential to create deadly new pathogens. Will any of these new ideas be adopted? We'll see. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 6, 2023 Category: Pharmaceuticals Authors: Steven Salzberg, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Experts Recommend New Limits On Dangerous Gain-Of-Function Research: Now What?
This past week, a government-appointed panel of scientists released a new report recommending 13 things the government should do to control “gain-of-function” research that has the potential to create deadly new pathogens. Will any of these new ideas be adopted? We'll see. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 6, 2023 Category: Pharmaceuticals Authors: Steven Salzberg, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

How Covid-19 Vaccines May Affect Your Menstrual Cycle, Here ’s What Studies Say
Studies have shown a temporary lengthening of their menstrual cycles can occur after Covid-19 vaccination. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 5, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

How Covid-19 Vaccines May Affect Your Menstrual Cycle, Periods
With so much bloody misinformation out there, it's a good time to cycle back and do a "period piece" on what real scientific studies have said to date. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 5, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

CH.1.1 ‘Orthrus’: How Concerning Is This New Covid-19 Subvariant?
The CH.1.1 Omicron subvariant now comprises about 10% of all the Covid-19 samples around the world. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 4, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

In Potential Breakthrough, Dutch Study Shows How Use Of a “DNA Medication Pass” Can Significantly Reduce Adverse Events
Researchers at the Leiden University Medical Center developed a “DNA medication pass” that connects a patient’s genetic profile to drugs of which it’s been shown that metabolic processing is influenced by DNA. Scanning the pass enables doctors to know what a patient's optimal medication dose is. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 3, 2023 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

Taking A Closer Look At Molnupiravir. Is Continued Use Justified?
Research suggests molnupiravir may supercharge new SARS-CoV-2 variants. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 3, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

Will Receptor Decoys Both Prevent And Treat SARS-CoV-2 Infection?
While ACE2 decoys have not worked against viruses in the past, can a receptor decoy work against the latest variants of SARS-CoV-2? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 3, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

Amazon ’s RxPass Adds To Its Pharmacy Footprint, But Doesn’t Really Compete With Mark Cuban’s Cost Plus Drug Company
Amazon is adding RxPass to its pharmacy footprint. Purportedly, it ’s competing with Mark Cuban’s Cost Plus Drug Company (MCCPDC). But, limitations suggest it isn’t yet a real competitor. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 3, 2023 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

Amazon ’s RxPass Doesn’t Yet Really Compete With Mark Cuban’s Cost Plus Drug Company
Amazon is adding RxPass to its pharmacy footprint. Purportedly, it ’s competing with Mark Cuban’s Cost Plus Drug Company (MCCPDC). But, limitations suggest it isn’t yet a real competitor. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 3, 2023 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

How ’s Your Congress Rep Doing? New Dashboard Shows Key Health Measures In 435 Districts
This Congressional District Health Dashboard (CDHD) can help you get better idea of how your Congressperson is actually doing. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 3, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Money /money Election 2020 /election-2020 business pharma Source Type: news